Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 457 to 465 of 465 entries
Sorted by: Best Match Show Resources per page
Hybrid epicardial ventricular tachycardia ablation with lateral thoracotomy in a patient with a history of left ventricular reconstruction surgery.

Journal of cardiology cases

Koya T, Watanabe M, Kamada R, Hagiwara H, Nakao M, Kadosaka T, Koizumi T, Anzai T.
PMID: 35024067
J Cardiol Cases. 2021 Jul 03;25(1):37-41. doi: 10.1016/j.jccase.2021.06.003. eCollection 2022 Jan.

Although a hybrid procedure involving surgical access may be feasible for epicardial catheter ablation in individuals with prior cardiac surgery, surgical approaches in thoracotomy are important in patients with advanced adhesions. We performed an epicardial ventricular tachycardia (VT) ablation...

Cite
Koya T, Watanabe M, Kamada R, et al. Hybrid epicardial ventricular tachycardia ablation with lateral thoracotomy in a patient with a history of left ventricular reconstruction surgery. J Cardiol Cases. 2021;25(1):37-41doi: 10.1016/j.jccase.2021.06.003.
Koya, T., Watanabe, M., Kamada, R., Hagiwara, H., Nakao, M., Kadosaka, T., Koizumi, T., & Anzai, T. (2022). Hybrid epicardial ventricular tachycardia ablation with lateral thoracotomy in a patient with a history of left ventricular reconstruction surgery. Journal of cardiology cases, 25(1), 37-41. https://doi.org/10.1016/j.jccase.2021.06.003
Koya, Taro, et al. "Hybrid epicardial ventricular tachycardia ablation with lateral thoracotomy in a patient with a history of left ventricular reconstruction surgery." Journal of cardiology cases vol. 25,1 (2022): 37-41. doi: https://doi.org/10.1016/j.jccase.2021.06.003
Koya T, Watanabe M, Kamada R, Hagiwara H, Nakao M, Kadosaka T, Koizumi T, Anzai T. Hybrid epicardial ventricular tachycardia ablation with lateral thoracotomy in a patient with a history of left ventricular reconstruction surgery. J Cardiol Cases. 2021 Jul 03;25(1):37-41. doi: 10.1016/j.jccase.2021.06.003. eCollection 2022 Jan. PMID: 35024067; PMCID: PMC8721263.
Copy Download .nbib Format: NLM
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.

Journal of diabetes investigation

Sawaguchi M, Araki SI, Kobori H, Urushihara M, Haneda M, Koya D, Kashiwagi A, Uzu T, Maegawa H.
PMID: 22822420
J Diabetes Investig. 2012 Jun;3(3):318-324. doi: 10.1111/j.2040-1124.2011.00172.x. Epub 2011 Nov 08.

AIMS/INTRODUCTION: Activation of the renin-angiotensin system (RAS) in the kidney plays an important role in renal function. The aim of this study was to investigate whether plasma and urinary angiotensinogen levels were associated with renal and cardiovascular prognosis in...

Cite
Sawaguchi M, Araki SI, Kobori H, et al. Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig. 2011;3(3):318-324doi: 10.1111/j.2040-1124.2011.00172.x.
Sawaguchi, M., Araki, S. I., Kobori, H., Urushihara, M., Haneda, M., Koya, D., Kashiwagi, A., Uzu, T., & Maegawa, H. (2012). Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. Journal of diabetes investigation, 3(3), 318-324. https://doi.org/10.1111/j.2040-1124.2011.00172.x
Sawaguchi, Makoto, et al. "Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus." Journal of diabetes investigation vol. 3,3 (2012): 318-324. doi: https://doi.org/10.1111/j.2040-1124.2011.00172.x
Sawaguchi M, Araki SI, Kobori H, Urushihara M, Haneda M, Koya D, Kashiwagi A, Uzu T, Maegawa H. Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig. 2012 Jun;3(3):318-324. doi: 10.1111/j.2040-1124.2011.00172.x. Epub 2011 Nov 08. PMID: 22822420; PMCID: PMC4014956.
Copy Download .nbib Format: NLM
An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan.

Infection control and hospital epidemiology

Nagano K, Kawasaki S, Moro H, Chang B, Bamba Y, Yamamoto A, Morita M, Ohnishi M, Shibata S, Koizumi T, Aoki N, Honma Y, Abe T, Koya T, Aoki N, Kikuchi T.
PMID: 34325756
Infect Control Hosp Epidemiol. 2021 Jul 30;1-3. doi: 10.1017/ice.2021.328. Epub 2021 Jul 30.

An outbreak of serotype 19A Streptococcus pneumoniae occurred among the residents of a relief facility. Pneumonia developed in 5 of 99 residents (attack rate, 5.1%). We obtained pharyngeal specimens from non-onset residents, and S. pneumoniae was isolated from 6...

Cite
Nagano K, Kawasaki S, Moro H, et al. An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan. Infect Control Hosp Epidemiol. 2021;1-3doi: 10.1017/ice.2021.328.
Nagano, K., Kawasaki, S., Moro, H., Chang, B., Bamba, Y., Yamamoto, A., Morita, M., Ohnishi, M., Shibata, S., Koizumi, T., Aoki, N., Honma, Y., Abe, T., Koya, T., Aoki, N., & Kikuchi, T. (2021). An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan. Infection control and hospital epidemiology, 1-3. https://doi.org/10.1017/ice.2021.328
Nagano, Kei, et al. "An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan." Infection control and hospital epidemiology vol. (2021): 1-3. doi: https://doi.org/10.1017/ice.2021.328
Nagano K, Kawasaki S, Moro H, Chang B, Bamba Y, Yamamoto A, Morita M, Ohnishi M, Shibata S, Koizumi T, Aoki N, Honma Y, Abe T, Koya T, Aoki N, Kikuchi T. An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan. Infect Control Hosp Epidemiol. 2021 Jul 30;1-3. doi: 10.1017/ice.2021.328. Epub 2021 Jul 30. PMID: 34325756.
Copy Download .nbib Format: NLM
Skin endometriosis: A case report and review of the literature.

Experimental and therapeutic medicine

Matei AM, Draghici-Ionescu AM, Cioplea M, Zurac SA, Boda D, Serban I, Caruntu C, Ilie MA, Fekete GL.
PMID: 33815605
Exp Ther Med. 2021 May;21(5):532. doi: 10.3892/etm.2021.9964. Epub 2021 Mar 23.

Skin endometriosis is a rare disease with variable clinical and histopathological characteristics that depend on hormonal stimuli. The skin is not a common location, as most cases of endometriosis involve pelvic sites, such as the ovaries, peritoneum and bowel....

Cite
Matei AM, Draghici-Ionescu AM, Cioplea M, et al. Skin endometriosis: A case report and review of the literature. Exp Ther Med. 2021;21(5):532doi: 10.3892/etm.2021.9964.
Matei, A. M., Draghici-Ionescu, A. M., Cioplea, M., Zurac, S. A., Boda, D., Serban, I., Caruntu, C., Ilie, M. A., & Fekete, G. L. (2021). Skin endometriosis: A case report and review of the literature. Experimental and therapeutic medicine, 21(5), 532. https://doi.org/10.3892/etm.2021.9964
Matei, Andreea-Mariana, et al. "Skin endometriosis: A case report and review of the literature." Experimental and therapeutic medicine vol. 21,5 (2021): 532. doi: https://doi.org/10.3892/etm.2021.9964
Matei AM, Draghici-Ionescu AM, Cioplea M, Zurac SA, Boda D, Serban I, Caruntu C, Ilie MA, Fekete GL. Skin endometriosis: A case report and review of the literature. Exp Ther Med. 2021 May;21(5):532. doi: 10.3892/etm.2021.9964. Epub 2021 Mar 23. PMID: 33815605; PMCID: PMC8014966.
Copy Download .nbib Format: NLM
Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer's Disease: A 6-Month Retrospective Follow-Up Study.

Current Alzheimer research

Dost FS, Kaya D, Ontan MS, Erken N, Bulut EA, Aydin AE, Isik AT.
PMID: 34939543
Curr Alzheimer Res. 2021;18(14):1087-1092. doi: 10.2174/1567205019666211221125255.

BACKGROUND: Alzheimer's Disease (AD) is still a great global challenge and agents with various mechanisms represent a promising therapeutic opportunity. Theracurmin, a very highly absorbable curcumin formulation, was shown to improve memory and attention in non-demented people.OBJECTIVE: The aim...

Cite
Dost FS, Kaya D, Ontan MS, et al. Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer's Disease: A 6-Month Retrospective Follow-Up Study. Curr Alzheimer Res. 2021;18(14):1087-1092doi: 10.2174/1567205019666211221125255.
Dost, F. S., Kaya, D., Ontan, M. S., Erken, N., Bulut, E. A., Aydin, A. E., & Isik, A. T. (2021). Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer's Disease: A 6-Month Retrospective Follow-Up Study. Current Alzheimer research, 18(14), 1087-1092. https://doi.org/10.2174/1567205019666211221125255
Dost, Fatma Sena, et al. "Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer's Disease: A 6-Month Retrospective Follow-Up Study." Current Alzheimer research vol. 18,14 (2021): 1087-1092. doi: https://doi.org/10.2174/1567205019666211221125255
Dost FS, Kaya D, Ontan MS, Erken N, Bulut EA, Aydin AE, Isik AT. Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer's Disease: A 6-Month Retrospective Follow-Up Study. Curr Alzheimer Res. 2021;18(14):1087-1092. doi: 10.2174/1567205019666211221125255. PMID: 34939543.
Copy Download .nbib Format: NLM
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.

Endocrine-related cancer

Nguyen H, Shah K, Waguespack SG, Hu MI, Habra MA, Cabanillas ME, Busaidy NL, Bassett R, Zhou S, Iyer PC, Simmons G, Kaya D, Pitteloud M, Subudhi SK, Diab A, Dadu R.
PMID: 33890870
Endocr Relat Cancer. 2021 Jun 02;28(7):419-431. doi: 10.1530/ERC-20-0513.

Data on the diagnosis, natural course and management of immune checkpoint inhibitor (ICI)-related hypophysitis (irH) are limited. We propose this study to validate the diagnostic criteria, describe characteristics and hormonal recovery and investigate factors associated with the occurrence and...

Cite
Nguyen H, Shah K, Waguespack SG, et al. Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns. Endocr Relat Cancer. 2021;28(7):419-431doi: 10.1530/ERC-20-0513.
Nguyen, H., Shah, K., Waguespack, S. G., Hu, M. I., Habra, M. A., Cabanillas, M. E., Busaidy, N. L., Bassett, R., Zhou, S., Iyer, P. C., Simmons, G., Kaya, D., Pitteloud, M., Subudhi, S. K., Diab, A., & Dadu, R. (2021). Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns. Endocrine-related cancer, 28(7), 419-431. https://doi.org/10.1530/ERC-20-0513
Nguyen, Ha, et al. "Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns." Endocrine-related cancer vol. 28,7 (2021): 419-431. doi: https://doi.org/10.1530/ERC-20-0513
Nguyen H, Shah K, Waguespack SG, Hu MI, Habra MA, Cabanillas ME, Busaidy NL, Bassett R, Zhou S, Iyer PC, Simmons G, Kaya D, Pitteloud M, Subudhi SK, Diab A, Dadu R. Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns. Endocr Relat Cancer. 2021 Jun 02;28(7):419-431. doi: 10.1530/ERC-20-0513. PMID: 33890870; PMCID: PMC8183642.
Copy Download .nbib Format: NLM
Characterization of High-Temperature Superconductor Bulks for Electrical Machine Application.

Materials (Basel, Switzerland)

Douine B, Berger K, Ivanov N, Samaan Z, Mbuagbaw L, Kosa D.
PMID: 33810598
Materials (Basel). 2021 Mar 26;14(7). doi: 10.3390/ma14071636.

High-temperature superconducting (HTS) bulks can be used in electrical applications. Experimental characterization of large-size HTS bulks is a tricky issue. The relevant parameters for their application were directly measured in this study. This paper has three main aims. Firstly,...

Cite
Douine B, Berger K, Ivanov N, et al. Characterization of High-Temperature Superconductor Bulks for Electrical Machine Application. Materials (Basel). 2021;14(7)doi: 10.3390/ma14071636.
Douine, B., Berger, K., Ivanov, N., Samaan, Z., Mbuagbaw, L., & Kosa, D. (2021). Characterization of High-Temperature Superconductor Bulks for Electrical Machine Application. Materials (Basel, Switzerland), 14(7), . https://doi.org/10.3390/ma14071636
Douine, Bruno, et al. "Characterization of High-Temperature Superconductor Bulks for Electrical Machine Application." Materials (Basel, Switzerland) vol. 14,7 (2021). doi: https://doi.org/10.3390/ma14071636
Douine B, Berger K, Ivanov N, Samaan Z, Mbuagbaw L, Kosa D. Characterization of High-Temperature Superconductor Bulks for Electrical Machine Application. Materials (Basel). 2021 Mar 26;14(7). doi: 10.3390/ma14071636. PMID: 33810598; PMCID: PMC8037854.
Copy Download .nbib Format: NLM
Severe Preeclampsia is Associated with Functional and Structural Cardiac Alterations: A Case-control Study.

Zeitschrift fur Geburtshilfe und Neonatologie

Kilic D, Guler T, Sevgican CI, Atigan A, Kilic O, Kaya D, Kilic ID.
PMID: 33836550
Z Geburtshilfe Neonatol. 2021 Apr 09; doi: 10.1055/a-1403-3585. Epub 2021 Apr 09.

BACKGROUND: The aim of the current study is to compare electrocardiographic and echocardiographic changes in patients with severe preeclampsia (PE) and those with uncomplicated pregnancies.METHODS: This is a case-controlled prospective study consisting of 21 pregnant women with severe preeclampsia...

Cite
Kilic D, Guler T, Sevgican CI, et al. Severe Preeclampsia is Associated with Functional and Structural Cardiac Alterations: A Case-control Study. Z Geburtshilfe Neonatol. 2021;doi: 10.1055/a-1403-3585.
Kilic, D., Guler, T., Sevgican, C. I., Atigan, A., Kilic, O., Kaya, D., & Kilic, I. D. (2021). Severe Preeclampsia is Associated with Functional and Structural Cardiac Alterations: A Case-control Study. Zeitschrift fur Geburtshilfe und Neonatologie, . https://doi.org/10.1055/a-1403-3585
Kilic, Derya, et al. "Severe Preeclampsia is Associated with Functional and Structural Cardiac Alterations: A Case-control Study." Zeitschrift fur Geburtshilfe und Neonatologie vol. (2021). doi: https://doi.org/10.1055/a-1403-3585
Kilic D, Guler T, Sevgican CI, Atigan A, Kilic O, Kaya D, Kilic ID. Severe Preeclampsia is Associated with Functional and Structural Cardiac Alterations: A Case-control Study. Z Geburtshilfe Neonatol. 2021 Apr 09; doi: 10.1055/a-1403-3585. Epub 2021 Apr 09. PMID: 33836550.
Copy Download .nbib Format: NLM
Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches.

Journal of clinical medicine

Xu J, Hirai T, Koya D, Kitada M.
PMID: 35011882
J Clin Med. 2021 Dec 27;11(1). doi: 10.3390/jcm11010137.

Atherosclerosis-caused cardiovascular diseases (CVD) are the leading cause of mortality in type 2 diabetes mellitus (T2DM). Sodium-glucose cotransporter 2 (SGLT2) inhibitors are effective oral drugs for the treatment of T2DM patients. Multiple pre-clinical and clinical studies have indicated that...

Cite
Xu J, Hirai T, Koya D, et al. Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010137.
Xu, J., Hirai, T., Koya, D., & Kitada, M. (2021). Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010137
Xu, Jing, et al. "Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010137
Xu J, Hirai T, Koya D, Kitada M. Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches. J Clin Med. 2021 Dec 27;11(1). doi: 10.3390/jcm11010137. PMID: 35011882; PMCID: PMC8745121.
Copy Download .nbib Format: NLM
Showing 457 to 465 of 465 entries